Vaccines (May 2020)

Uncovering Distinct Primary Vaccination-Dependent Profiles in Human <i>Bordetella pertussis</i> Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay

  • Eleonora E. Lambert,
  • Véronique Corbière,
  • Jacqueline A. M. van Gaans-van den Brink,
  • Maxime Duijst,
  • Prashanna Balaji Venkatasubramanian,
  • Elles Simonetti,
  • Martijn Huynen,
  • Dimitri D. Diavatopoulos,
  • Pauline Versteegen,
  • Guy A. M. Berbers,
  • Françoise Mascart,
  • Cécile A. C. M. van Els

DOI
https://doi.org/10.3390/vaccines8020225
Journal volume & issue
Vol. 8, no. 2
p. 225

Abstract

Read online

To advance research and development of improved pertussis vaccines, new immunoassays are needed to qualify the outcome of Bordetella pertussis (Bp) specific CD4+ T-cell differentiation. Here, we applied a recently developed whole blood assay to evaluate Bp specific CD4+ T-cell responses. The assay is based on intracellular cytokine detection after overnight in vitro Bp antigen stimulation of diluted whole blood. We show for the first time that CD4+ T-cell memory of Th1, Th2, and Th17 lineages can be identified simultaneously in whole blood. Participants ranging from 7 to 70 years of age with different priming backgrounds of whole-cell pertussis (wP) and acellular pertussis (aP) vaccination were analyzed around an acellular booster vaccination. The assay allowed detection of low frequent antigen-specific CD4+ T-cells and revealed significantly elevated numbers of activated and cytokine-producing CD4+ T-cells, with a significant tendency to segregate recall responses based on primary vaccination background. A stronger Th2 response hallmarked an aP primed cohort compared to a wP primed cohort. In conclusion, analysis of Bp specific CD4+ T-cell responses in whole blood showed separation based on vaccination background and provides a promising tool to assess the quantity and quality of CD4+ T-cell responses induced by vaccine candidates.

Keywords